| Katherine E Fitzgerald, DO | |
|
266 Main St, Heywood Family Medicine, Gardner, MA 01440-2927 | |
| (978) 630-5030 | |
| (978) 630-5033 |
| Full Name | Katherine E Fitzgerald |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 266 Main St, Gardner, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134357346 | NPI | - | NPPES |
| 110094256A | Medicaid | MA | |
| M21141 | Other | MA | MEDICARE GROUP# - FAMILY MEDICAL & MATERNITY CARE, PC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 249736 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gvna Healthcare Inc | Gardner, MA | Home health agency |
| Heywood Hospital - | Gardner, MA | Hospital |
| Athol Memorial Hospital | Athol, MA | Hospital |
| Healthalliance Hospitals, Inc | Leominster, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Heywood Memorial Hospital | 1658262605 | 61 |
| Heywood Medical Group Inc. | 6901882836 | 82 |
| Athol Memorial Hospital Incorporated | 7911959846 | 65 |
News Archive
Jude Children's Research Hospital reports success using a targeted educational approach to teach young patients to remain motionless during MRI scans, making the process safer.
Biovista Inc. today announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
In recognition of Black History Month, House Majority Whip James E. Clyburn is urging African Americans with diabetes to get an annual diabetic eye exam during February.
› Verified 8 days ago
| Entity Name | Henry Heywood Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205823879 PECOS PAC ID: 1658262605 Enrollment ID: O20040322000360 |
News Archive
Jude Children's Research Hospital reports success using a targeted educational approach to teach young patients to remain motionless during MRI scans, making the process safer.
Biovista Inc. today announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
In recognition of Black History Month, House Majority Whip James E. Clyburn is urging African Americans with diabetes to get an annual diabetic eye exam during February.
› Verified 8 days ago
| Entity Name | Heywood Medical Group Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699762286 PECOS PAC ID: 6901882836 Enrollment ID: O20040629001351 |
News Archive
Jude Children's Research Hospital reports success using a targeted educational approach to teach young patients to remain motionless during MRI scans, making the process safer.
Biovista Inc. today announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
In recognition of Black History Month, House Majority Whip James E. Clyburn is urging African Americans with diabetes to get an annual diabetic eye exam during February.
› Verified 8 days ago
| Entity Name | Athol Memorial Hospital Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336120047 PECOS PAC ID: 7911959846 Enrollment ID: O20050218000228 |
News Archive
Jude Children's Research Hospital reports success using a targeted educational approach to teach young patients to remain motionless during MRI scans, making the process safer.
Biovista Inc. today announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
In recognition of Black History Month, House Majority Whip James E. Clyburn is urging African Americans with diabetes to get an annual diabetic eye exam during February.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine E Fitzgerald, DO 266 Main St, Heywood Family Medicine, Gardner, MA 01440-2927 Ph: (978) 630-5030 | Katherine E Fitzgerald, DO 266 Main St, Heywood Family Medicine, Gardner, MA 01440-2927 Ph: (978) 630-5030 |
News Archive
Jude Children's Research Hospital reports success using a targeted educational approach to teach young patients to remain motionless during MRI scans, making the process safer.
Biovista Inc. today announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
In recognition of Black History Month, House Majority Whip James E. Clyburn is urging African Americans with diabetes to get an annual diabetic eye exam during February.
› Verified 8 days ago
Diane Rahman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 27 Heywood St, Gardner, MA 01440 Phone: 978-632-4097 | |
Mrs. Sherry Lillian Rickan, FNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 242 Green St, Gardner, MA 01440 Phone: 978-630-5050 | |
Michele C. Parker, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Green St, Gardner, MA 01440 Phone: 978-669-0199 Fax: 978-669-0054 | |
Dr. Kim D Houde, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Connors St, Gardner, MA 01440 Phone: 978-410-6100 | |
John Worden, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Green St, Gardner, MA 01440 Phone: 978-630-6445 Fax: 978-630-3603 | |
Dr. Timothy J Eddy, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 266 Main St, Gardner, MA 01440 Phone: 978-630-5030 |